Viewing Study NCT01546532


Ignite Creation Date: 2025-12-24 @ 9:42 PM
Ignite Modification Date: 2026-01-06 @ 10:39 PM
Study NCT ID: NCT01546532
Status: COMPLETED
Last Update Posted: 2020-12-19
First Post: 2012-03-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Renal Hemodynamic Effects of RLX030A in Subjects With Chronic Heart Failure (CHF)
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module